08.01.14
Responding to a rise in new, often fatal infectious agents in healthcare and other public settings, Lonza’s Hygiene & Preservation business has gained US EPA approval for several of its disinfectant formulations: the Lonzagard R82 family of products. Wipes Plus disinfectant wipes and Plus 2 disinfectant wipes have been approved to combat the dangerous new avian influenza A (H7N9) virus and Candida Albicans, a bloodstream infection prevalent in hospitals, on hard nonporous surfaces.
Avian influenza A (H7N9) virus human infections were first reported in China in March 2013 and have now spread beyond its borders, according to the US Centers for Disease Control.
More info: www.lonzabiocides.com
Avian influenza A (H7N9) virus human infections were first reported in China in March 2013 and have now spread beyond its borders, according to the US Centers for Disease Control.
More info: www.lonzabiocides.com